Adjunctive trimetazidine in patients undergoing primary PCI for STEMI
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2013
Price : $35 *
At a glance
- Drugs Trimetazidine (Primary)
- Indications Myocardial infarction; Myocardial ischaemia
- Focus Therapeutic Use
- 28 Sep 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 01 Sep 2013 Primary endpoint 'Myocardial-infarct-size' has not been met.